Current Opinion in Oncology

Article	Citations
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?	50
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy	38
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies	30
Harnessing dendritic cells for innovative therapeutic cancer vaccines	26
Progress in diagnosis and treatment of checkpoint inhibitor pneumonitis	24
Content features and its implementation in novel app-based psycho-oncological interventions for cancer survivors: a narrative review	24
Role of PSMA PET/CT in imaging and management of prostate cancer	21
Neurorehabilitation in brain tumours: evidences and suggestions for spreading of knowledge and research implementation	21
Collecting information from all sarcoma reference cancer centres worldwide: achievement and next steps	20
Editorial introductions	18
Treatments and challenges in advanced prostate cancer	18
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies	18
First and further-line multidisciplinary treatment of retroperitoneal sarcomas	17
Psycho-oncology interventions focusing on fatigue and sleep disturbances	16
Editorial introductions	15
Epigenetic dynamics of aging and cancer development: current concepts from studies mapping aging and cancer epigenomes	15
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients	14
Safety of assisted reproductive techniques in gynecological cancer patients	14
New hopes in relapsed refractory primary central nervous system lymphoma	14
Editorial introductions	14
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?	14
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies	14
Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers	13
How to prevent human papillomavirus-related oropharyngeal cancer?	13
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making	13

Neoadjuvant and adjuvant approaches in gastroesophageal cancers	13
Indications and technique of minimally invasive surgery in early-stage cervical cancer	12
Biomarkers and immunotherapy: where are we?	12
Editorial introductions	12
WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification	12
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma	11
Open questions on vorasidenib	11
Melanoma with genetic alterations beyond the BRAF V600 mutation: management and new insights	11
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women?	11
Editorial introductions	11
Enhancing proactive life-sustaining treatment preference documentation in advanced cancer care: barriers and recommendations	11
Recent advances in precision medicine for acute myeloid leukemia	10
Immunomodulation for hepatocellular carcinoma therapy: current challenges	10
Antibody–drug conjugates in rare genitourinary tumors: review and perspectives	10
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies	10
Liquid biopsy in brain tumors: moving on, slowly	10
Circulating tumor DNA in breast cancer: a biomarker for patient selection	10
Dyadic psychosocial interventions for patients with cancer and their caregivers: an update	10
A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?	10
Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results	10
Editorial introductions	9
Lung cancer screening in never smokers	9
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials	8
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations	8
Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients	8
Machine learning applications and challenges in graft-versus-host disease: a scoping review	8
A new comprehensive and stratified concept for supportive care in cancer patients	8
How to become a Multinational Association of Supportive Care in Cancer-designated center of excellence in supportive care in cancer	8
Pathology and new insights in central nervous system lymphomas	8
Hybrid magnetic resonance and PET imaging for prostate cancer recurrence	8
Current evidence of integrative oncology modalities for managing adverse effects and survivorship issues among adolescents and young adult (AYA) cancer patients and survivors	8
The role of genetic testing in prostate cancer screening, diagnosis, and treatment	8
The 5T's of health disparities in multiple myeloma in Latin America	8
Desmoid tumors: who, when and how to treat?	8
Current role and indications of minimally invasive surgery in gynecologic oncology	7
State of the art and upcoming trends in claudin-directed therapies in gastrointestinal malignancies	7
Potential application of artificial intelligence in cancer therapy	7
Editorial introductions	7
Editorial introductions	7
Editorial introductions	7
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)	7
Application of single-port techniques in endometrial cancer	7
Advantages of robotic surgery in obese patients with endometrial cancer	7
Mind the target: programmed death ligand 1 in oesophagogastric cancers	7
New therapies for brain metastases: an update	7
Question prompt lists to improve communication between cancer patients and healthcare professionals	6
Sarcoma incidence worldwide: regional differences in histology and molecular subtypes	6
How to support parenting in patients with cancer and co-parents? From research to practice	6
Pathologic diagnosis of lung cancer – recent developments	6
Adjuvant and neoadjuvant approaches in pancreatic cancer	6

Treatment of radiation-associated angiosarcoma	6
Cellular therapies in sarcoma and other solid tumors	6
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancer	6
Targeting cancer stem cell pathways for lung cancer therapy	6
Breast surgery after neoadjuvant therapy	6
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification	6
Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results	6
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments	6
When do I ask for a DNA methylation array for primary brain tumor diagnosis?	6
The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy	6
Preclinical glioma models in neuro-oncology: enhancing translational research	6
Editorial introductions	6
HER2-positive breast cancer: cotargeting to overcome treatment resistance	6
HIV-related lymphomas	5
Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer	5
Achievements of international rare cancers networks and consortia in the neuro-oncology field	5
Molecular oncology: what is needed to speed access to innovative therapies in clinical research?	5
Current status of phosphoinotiside-3 kinase inhibitors in blood cancers	5
Polyamine metabolism in prostate cancer	5
Precision, personalization, and quality of life for patients with lymphoma	5
How to monitor the side effects of treatments in cancer patients	5
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine	5
Thymic malignancies: role of immunotherapy and novel approaches	5
Update on bi-specific monoclonal antibodies for blood cancers	5
How to treat localized Hodgkin lymphoma?	5
Surgical treatment for clinical early-stage expansile and infiltrative mucinous ovarian cancer: can staging surgeries safely be omitted?	5
Immunotherapies in non-metastatic gastrointestinal cancers	5
Therapeutic cancer vaccination against telomerase: clinical developments in melanoma	5
Editorial introductions	5
Endoscopic inguinal lymphadenectomy for vulvar cancer, is it feasible?	5
Clinical management of brain tumors in pregnancy	5
Patient-proxy agreement on health-related quality of life assessment in cancer patients	5
Richter transformation: biological insights, diagnostic challenges and emerging therapies	5
Immunotherapy of sarcomas with modified T cells	4
Preoperative immunotherapy for head and neck cancers: state of art	4
Ovarian stimulation and oocyte cryopreservation in females with cancer	4
Targeting exon 20 insertion mutations in lung cancer	4
Recent advances in immunotherapy for small cell lung cancer	4
Current opinion on laparoscopic surgery in gynecologic oncology: challenges and advances in elderly patients	4
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomas	4
Are epigenetic-targeting approaches ready for prime time in neuroendocrine neoplasms?	4
Perioperative immunotherapy in nonsmall cell lung cancer	4
Editorial introductions	4
Is there role of adjuvant radiotherapy after complete resection of locally advanced nonsmall cell lung cancer?	4
Molecular genotyping in medullary thyroid cancer	4
Vascular complications in patients with brain tumors	4
High-risk smoldering myeloma – a case for early intervention?	4
Predictors of response to CD19 chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a consolidated review	4
New trends in supportive care of head and neck cancers	4
Update of antibody–drug conjugates for hematological malignancies	4
Early Detection of Cancers in the Era of Precision Oncology	4
RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice	4
Doxorubicin combined with Trabectedin in systemic first-line M+/recurrent leiomyosarcoma patients	4
New treatment strategies for primary central nervous system lymphoma	3
Implementation of the 2024 ASCO guidelines for the prevention and management of osteoradionecrosis in patients with head & neck cancer treated with radiation therapy	3
Clinician's guide to targeted estrogen receptor degradation using PROTAC in patients with estrogen receptor-positive metastatic breast cancer	3
Targeting androgen receptors in patients with metastatic breast cancer	3
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer	3
New strategies for the treatment of breast cancer with leptomeningeal metastasis	3
Precision medicine in extended adjuvant endocrine therapy for breast cancer	3
How to treat advanced Hodgkin lymphoma?	3
Editorial: Psychological interventions in oncology: advances and challenges	3
The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma	3
Action against thoracic cancers: recent achievements and perspectives	3
CIC-DUX4 sarcomas	3
Editorial: Advanced care planning	3
New targeted treatments for advanced sarcomas	3
Postneoadjuvant treatment for triple-negative breast cancer	3
Minimally invasive surgery in advanced and recurrent ovarian cancer: current evidence and future directions	3
Future of sentinel node biopsy in ovarian cancer	3
Editorial introductions	3
Monitoring serum estradiol in premenopausal women with hormone receptor-positive breast cancer on adjuvant LHRH agonists	3
Evolving systemic management of urothelial cancers	3
Cancer-associated thrombosis: what is new?	3
Advances in testing for human papillomavirus-mediated head and neck cancer	3
Immunotherapy for inflammatory breast cancer: current evidences and future perspectives	3
Challenges in the management of relapsed germ cell tumors	3
Epidemiology trends and progress in breast cancer survival: earlier diagnosis, new therapeutics	3
Advances in the treatment of light chain amyloidosis	3
Circulating tumour DNA dynamics for assessment of molecular residual disease and for intercepting resistance in breast cancer	3

Recent advances in allogeneic transplantation for acute myeloid leukemia	3
Novel therapeutic agents for myelofibrosis after failure or suboptimal response to JAK2 inhbitors	3
Optimizing the prescription doses and tolerability of systemic therapy in head and neck cancer patients	3
Robot-assisted laparoscopic staging compared to conventional laparoscopic staging and laparotomic staging in clinical early stage ovarian carcinoma	3
New treatments for desmoid tumors	3
Editorial introductions	3
Unveiling the role of cellular dormancy in cancer progression and recurrence	3
Sarculator: how to improve further prognostication of all sarcomas	2
Highlights of recent research focused on the treatment of advanced prostate cancer	2
Management of epilepsy in brain tumor patients	2
Emerging therapies in Ewing sarcoma	2
Liquid biopsy in head neck cancer: ready for clinical routine diagnostics?	2
Advance care planning in oncology: a scoping review and some recommendations	2
Perioperative immunotherapy for nonsmall cell lung cancer	2
Interventions for children of parents with cancer: an overview	2
The role of next-generation sequencing in acute myeloid leukemia	2
Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives	2
Immuno-oncology in the daily practice	2
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence	2
Editorial: Advances in cancer detection and diagnosis: from liquid biopsies and molecular biomarkers to opportunistic intratumoral bacteria	2
Targeting Harvey rat sarcoma viral oncogene homolog in head and neck cancer: how to move forward?	2
First line treatments in primary central nervous system lymphomas in young patients	2
Treatment approaches for older Hodgkin lymphoma patients	2
Neoadjuvant chemotherapy for resectable colon cancer in the era of precision oncology: a step forward or a step back?	2
Novel immunotherapeutic approaches in lung cancer: driving beyond programmed death-1/programmed death ligand-1 and cytotoxic T-lymphocyte-associated Protein-4	2
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: from current standards to precision medicine	2
The role of menin inhibitors in acute myeloid leukemia	2
Use of staging for sex cord stromal tumours	2
Editorial: Less is more in gynaecological oncology: paving the way for the future	2
Editorial Introductions	2
T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities	2
Active surveillance in favorable intermediate risk prostate cancer: outstanding questions and controversies	2
Editorial: ’All you need is immunotherapy’: a new treatment paradigm in sight for early-stage, mismatch repair-deficient/microsatellite instability high gastrointestinal cancers?	2
Circulating tumor DNA in B cell lymphomas	2
Getting personal in metastatic melanoma: neoantigen-based vaccines as a new therapeutic strategy	2
Systemic treatment of recurrent and/or metastatic squamous cell carcinomas of the head and neck: what is the best therapeutic sequence?	2
Neoadjuvant chemotherapy for patients with locally advanced vulvar cancer	2
A meta-analysis on the risk of infection associated with intravenous iron therapy in cancer-associated anaemia: a double-edged sword?	2
Clinical utility of genomic signatures for the management of early and metastatic triple-negative breast cancer	2